Psychoactive Drugs: Mechanisms of Action and Behavioral Effects

Core Idea

Psychoactive drugs alter behavior by modulating neurotransmission. Depressants (alcohol, benzodiazepines) enhance GABA inhibition; stimulants (cocaine, amphetamines) increase dopamine; hallucinogens modulate serotonin and glutamate; opioids activate mu receptors. The behavioral effect depends on drug class, dosage, administration route, individual neurochemistry, and context. Chronic use causes tolerance (reduced response), withdrawal (compensatory changes), and sensitization (enhanced response to cues).

Explainer

From your study of pharmacology, you know that drugs act as agonists (mimicking or enhancing a signal) or antagonists (blocking it). Psychoactive drugs apply this principle to specific neurotransmitter systems, and the behavioral outcome maps predictably onto which system is targeted. The brain's excitatory/inhibitory balance — maintained by glutamate and GABA — is the foundation. Depressants like alcohol and benzodiazepines tip this balance toward inhibition by enhancing GABA activity, producing sedation, anxiolysis, and at high doses, anesthesia. This is why a few drinks feel relaxing: you are globally reducing neural excitability. The flip side is that their withdrawal is dangerous — removing the enhanced inhibition leaves a hyperexcitable brain.

Stimulants work primarily through the dopamine system, which you know mediates reward and motivation. Cocaine blocks the dopamine transporter (DAT), preventing reuptake and flooding the synapse. Amphetamines are more aggressive: they reverse the transporter, actively pumping dopamine *out* of the presynaptic cell. Both produce intense reward, increased energy, and focused arousal, but through slightly different mechanisms. The reward is disproportionate to what any natural stimulus produces, which is why stimulant use can make natural rewards feel flat by comparison — a process that underlies tolerance and the motivational deficits of addiction.

Hallucinogens like LSD and psilocybin primarily act as partial agonists at serotonin 5-HT₂A receptors in the cortex. This receptor normally helps modulate how the cortex integrates sensory information with predictions and prior beliefs. When overactivated, the thalamic "gate" that filters sensory input loosens, and cortical circuits that are normally quiet become active — producing perceptual distortions, altered sense of self, and novel associative thinking. Opioids occupy a different mechanism entirely: they activate mu-opioid receptors on GABAergic interneurons in the reward circuit, effectively disinhibiting dopamine neurons and releasing a flood of dopamine. They also directly suppress pain by acting on receptors in the spinal cord and periaqueductal gray.

Tolerance, withdrawal, and sensitization are the three ways the brain adapts to repeated drug exposure, and they point in different directions. Tolerance occurs when the brain compensates for a drug's presence (e.g., downregulating receptors), requiring more drug for the same effect. Withdrawal is the rebound when the drug is removed and the compensatory changes are unmasked. Sensitization is more interesting: while the subjective high often tolerates, the brain can become *more* reactive to drug-associated cues — the sight of a needle, a familiar smell, a location. This cue-induced sensitization explains why cravings can be triggered even after years of abstinence, and why context matters so much in treatment settings. The same pharmacological mechanism that produces a drug's acute effect is often the seed of both its therapeutic value and its potential for misuse.